tiprankstipranks
Trending News
More News >

Shanghai Pharmaceuticals Approves Key Resolutions at 2024 AGM

Story Highlights
Shanghai Pharmaceuticals Approves Key Resolutions at 2024 AGM

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).

Shanghai Pharmaceuticals Holding Co., Ltd. recently held its 2024 Annual General Meeting (AGM) in Shanghai, where key resolutions, including the approval of the 2024 Annual Report and the Report of the Board of Directors, were passed with overwhelming support. The AGM was conducted in compliance with relevant legal and regulatory requirements, and it saw participation from a significant number of shareholders, underscoring the company’s strong governance and stakeholder engagement.

The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.

More about Shanghai Pharmaceuticals Holding Co

Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the production and distribution of pharmaceutical products. The company operates with a significant market presence in both A Shares and H Shares, reflecting its broad shareholder base and influence in the market.

Average Trading Volume: 7,261,365

Technical Sentiment Signal: Hold

Current Market Cap: HK$65.18B

See more insights into 2607 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1